|
|
Jeff is a Serial Entrepreneur. While completing his undergraduate studies at Harvard he founded the Telluride Group (Healthcare Managed Services IT firm). At Telluride Jeff led a $1 Million angel round and eventually oversold the eventual acquisition of the group. He later went on to found Biogen’s incubation group and launch Provasculon and Escoublac. More recently he formed Predictive Biology Analytics from an SBIR grant. He is currently at Edimer Pharmaceuticals, where he was the 2nd employee. And just to round it all off he lead two rounds of angel financing at Finale Restaurants. He holds an MBA from MIT Sloan and a Masters of Health Sciences and Technology from MIT/Harvard.
|
|
Video Length: 170
Date Found: September 30, 2010
Date Produced: September 21, 2010
|
|
 MIT TechTV |
July 13, 2011
|
 MIT TechTV |
July 07, 2011
|
 MIT TechTV |
June 27, 2011
The emerging cleantech venture`s pilot has been supported by government grants now it is time to scale. Cleantech requires significant funding, often larger than traditional vc`s are structured to support. How does a cleantech venture scale to grow? Hear from national project developer ...
|
 MIT TechTV |
June 27, 2011
Three leading New York venture capital firms will provide their strategies for 2011. Understanding venture capital firms’ strategies is critical in order to obtain venture capital. Prior to the panel discussion, PwC will present a summary of the 3rd quarter 2010 MoneyTree Report. The MoneyTree ...
|
 MIT TechTV |
June 27, 2011
With the recent passage of healthcare reform legislation, corporate consolidations, and a `get tough` policy at the FDA, it is difficult to tell what the commercial healthcare landscape will look like during the next five years. A distinguished panel of experts representing biopharmaceuticals, ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|